BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23092812)

  • 21. [Effect of donor CD4+CD25+ regulatory T cells on hematopoietic and immune reconstitution, GVHD and disease-free survival after allogeneic hematopoietic stem cell transplantation].
    Yang K; Fan ZP; Liu QF; Zhang Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Apr; 28(4):537-41. PubMed ID: 18495584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Time-course and risk factors of hypothyroidism following allogeneic hematopoietic stem cell transplantation (HSCT) in children conditioned with fractionated total body irradiation.
    Bailey HK; Kappy MS; Giller RH; Gralla J
    Pediatr Blood Cancer; 2008 Sep; 51(3):405-9. PubMed ID: 18523993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired B-cell reconstitution in lymphoma patients undergoing allogeneic HSCT: an effect of pretreatment with rituximab?
    Buser A; Stern M; Arber C; Medinger M; Halter J; Rovo A; Favre G; Lohri A; Tichelli A; Gratwohl A
    Bone Marrow Transplant; 2008 Oct; 42(7):483-7. PubMed ID: 18695668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Related HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: observations of a single Chinese center.
    Huang X; Liu D
    Clin Transpl; 2011; ():237-45. PubMed ID: 22755417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transplantation-related mortality, graft failure, and survival after reduced-toxicity conditioning and allogeneic hematopoietic stem cell transplantation in 100 consecutive pediatric recipients.
    Satwani P; Jin Z; Duffy D; Morris E; Bhatia M; Garvin JH; George D; Bradley MB; Harrison L; Petrillo K; Schwartz J; Foley S; Hawks R; Baxter-Lowe LA; Cairo MS
    Biol Blood Marrow Transplant; 2013 Apr; 19(4):552-61. PubMed ID: 23253557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune reconstitution after allogeneic stem cell transplantation: the impact of stem cell source and graft-versus-host disease.
    Abrahamsen IW; Sømme S; Heldal D; Egeland T; Kvale D; Tjønnfjord GE
    Haematologica; 2005 Jan; 90(1):86-93. PubMed ID: 15642674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of donor-recipient major ABO mismatch on allogeneic transplantation outcome according to stem cell source.
    Blin N; Traineau R; Houssin S; Peffault de Latour R; Petropoulou A; Robin M; Larghero J; Ribaud P; Socié G
    Biol Blood Marrow Transplant; 2010 Sep; 16(9):1315-23. PubMed ID: 20353831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human cytomegalovirus-specific T cell reconstitution in young patients receiving T cell-depleted, allogeneic hematopoietic stem cell transplantation.
    Lilleri D; Gerna G; Fornara C; Chiesa A; Comolli G; Zecca M; Locatelli F
    J Infect Dis; 2009 Mar; 199(6):829-36. PubMed ID: 19239337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphocyte subset recovery and outcome after T-cell replete allogeneic hematopoietic SCT.
    Bühlmann L; Buser AS; Cantoni N; Gerull S; Tichelli A; Gratwohl A; Stern M
    Bone Marrow Transplant; 2011 Oct; 46(10):1357-62. PubMed ID: 21113185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes of unrelated cord blood transplants and allogeneic-related hematopoietic stem cell transplants in children with high-risk acute lymphocytic leukemia.
    Jacobsohn DA; Hewlett B; Ranalli M; Seshadri R; Duerst R; Kletzel M
    Bone Marrow Transplant; 2004 Nov; 34(10):901-7. PubMed ID: 15361908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Matched sibling versus matched unrelated allogeneic hematopoietic stem cell transplantation in children with severe acquired aplastic anemia: experience of the polish pediatric group for hematopoietic stem cell transplantation.
    Szpecht D; Gorczyńska E; Kałwak K; Owoc-Lempach J; Choma M; Styczyński J; Goździk J; Dłużniewska A; Wysocki M; Kowalczyk JR; Chybicka A; Pieczonka A; Wachowiak J
    Arch Immunol Ther Exp (Warsz); 2012 Jun; 60(3):225-33. PubMed ID: 22527354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune Reconstitution Profiling Suggests Antiviral Protection after Transplantation with Omidubicel: A Phase 3 Substudy.
    Szabolcs P; Mazor RD; Yackoubov D; Levy S; Stiff P; Rezvani A; Hanna R; Wagner J; Keating A; Lindemans CA; Karras N; McGuirk J; Hamerschlak N; López-Torija I; Sanz G; Valcarcel D; Horwitz ME
    Transplant Cell Ther; 2023 Aug; 29(8):517.e1-517.e12. PubMed ID: 37120136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T cell regeneration in pediatric allogeneic stem cell transplantation.
    Olkinuora H; Talvensaari K; Kaartinen T; Siitonen S; Saarinen-Pihkala U; Partanen J; Vettenranta K
    Bone Marrow Transplant; 2007 Feb; 39(3):149-56. PubMed ID: 17211435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative and qualitative CD4 T cell immune responses related to adenovirus DNAemia in hematopoietic stem cell transplantation.
    Guérin-El Khourouj V; Dalle JH; Pédron B; Yakouben K; Bensoussan D; Cordeiro DJ; Peltier L; Ouachée-Chardin M; Baruchel A; Sterkers G
    Biol Blood Marrow Transplant; 2011 Apr; 17(4):476-85. PubMed ID: 20869455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of immune reconstitution after autologous bone marrow transplantation in systemic sclerosis.
    Farge D; Henegar C; Carmagnat M; Daneshpouy M; Marjanovic Z; Rabian C; Ilie D; Douay C; Mounier N; Clave E; Bengoufa D; Cabane J; Marolleau JP; Gluckman E; Charron D; Toubert A
    Arthritis Rheum; 2005 May; 52(5):1555-63. PubMed ID: 15880600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delayed immune reconstitution after allogeneic transplantation increases the risks of mortality and chronic GVHD.
    Bejanyan N; Brunstein CG; Cao Q; Lazaryan A; Luo X; Curtsinger J; Mehta RS; Warlick E; Cooley SA; Blazar BR; Miller JS; Weisdorf D; Wagner JE; Verneris MR
    Blood Adv; 2018 Apr; 2(8):909-922. PubMed ID: 29678809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reconstitution of natural killer cell receptor repertoires after unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation: analyses of CD94:NKG2A and killer immunoglobulin-like receptor expression and their associations with clinical outcome.
    Zhao XY; Huang XJ; Liu KY; Xu LP; Liu DH
    Biol Blood Marrow Transplant; 2007 Jun; 13(6):734-44. PubMed ID: 17531784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune reconstitution and production of intracellular cytokines in T lymphocyte populations following autologous peripheral blood stem cell transplantation.
    Schlenke P; Sheikhzadeh S; Weber K; Wagner T; Kirchner H
    Bone Marrow Transplant; 2001 Aug; 28(3):251-7. PubMed ID: 11535992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Outcome of allogeneic hematopoietic stem cell transplantation from HLA-matched sibling donor for 41 cases of severe aplastic anemia].
    Chen X; Wei JL; Huang Y; He Y; Yang DL; Jiang EL; Ma QL; Zhou LK; Lin XT; Shen YY; Feng SZ; Han MZ
    Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):610-4. PubMed ID: 23134851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune recovery after in vivo T-cell depletion myeloablative conditioning hematopoietic stem cell transplantation in severe beta-thalassemia children.
    Qin F; Shi L; Li Q; Zhang Z; Liu L; Li J; Yang G; Lai YR
    Eur J Haematol; 2019 Oct; 103(4):342-350. PubMed ID: 31276236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.